How AI Is Transforming Pharma Sales & Marketing
DHC Group · Disruptive Dose
From patient support to AI answer engines: how pharma can rethink automation, content, and engagement as AI adoption accelerates.
View post
Thought Leadership Portfolio
AI & Digital Innovation Leader | Speaker & Startup AdvisorFormer BMS & Novartis Executive | Founder of #GenAI4Pharma
DHC Group · Disruptive Dose
From patient support to AI answer engines: how pharma can rethink automation, content, and engagement as AI adoption accelerates.
View postCure
What angel investors look for: a measurable business problem, a strong team, customer insight, and investors whose fit and networks support growth.
View postCure · #GenAI4Pharma NYC
Coverage of my #GenAI4Pharma NYC event: five experts on AI-powered biology, women’s health, medical writing, and the teams bringing innovation to market.
View postImpatient Health
Speaking and panel participation in an innovation forum challenging conventional pharma models and exploring a more effective future.
View postHealth Disruptors · SignalFire
Bringing pharma and startups together to explore GenAI applications across discovery, clinical development, medical, and commercial functions.
View postEndpoints News
Drawing on pharma’s early Twitter experience to consider what brands can learn from Threads—and why observation comes before adoption.
View postSpringboard Enterprises
Supporting women-led healthcare ventures through strategic guidance, mentorship, and connections across the life sciences ecosystem.
View postteachintwo
From R&D to commercial content: exploring GenAI’s potential in pharma, implementation challenges, and the global #GenAI4Pharma series.
View postBentley University
What does effective AI adoption require? Panel perspectives on workforce readiness, human skills, and organizational change.
View postDayOne · BOOM Summit
Speaking and panel participation at Basel’s healthtech summit, connecting healthcare leaders with the technology innovation ecosystem.
View postDTx East
What experienced DTx leaders wish they had known earlier: business models, market entry, investment, and emerging opportunities.
View postImpatient Health
How modular design, thoughtful processes, and human judgment can help AI produce content that is meaningful rather than overwhelming.
View postSpringboard Enterprises
Moderating the 2024 accelerator cohort’s showcase of women-led healthcare and technology ventures at JPM 2025.
View postDHC Group · Disruptive Dose
Exploring where GenAI can create practical value—from content and automation to patient support—and how to approach compliance.
View postLife Sciences Dreamin’
Why promising ideas stall inside big companies—and practical ways to navigate organizational barriers and avoid innovation traps.
View postDigital Health Coalition · AstraZeneca
How generative AI could reshape pharma marketing and communications while keeping patients at the center of digital transformation.
View postSXSW 2022
Moderating a discussion on how AI, decentralized trials, and strategic partnerships could improve equity across drug development.
View postReuters Events Pharma
Why pharma’s competitive advantage depends on culture change, patient data, and product teams that support digital therapies beyond launch.
View post